458 related articles for article (PubMed ID: 32234403)
21. [Autoimmune liver diseases].
Fischer HP; Goltz D
Pathologe; 2020 Sep; 41(5):444-456. PubMed ID: 32749523
[TBL] [Abstract][Full Text] [Related]
22. The impact of human leukocyte antigen donor and recipient serotyping and matching on liver transplant graft failure in primary sclerosing cholangitis, autoimmune hepatitis, and primary biliary cholangitis.
Patel YA; Henson JB; Wilder JM; Zheng J; Chow SC; Berg CL; Knechtle SJ; Muir AJ
Clin Transplant; 2018 Oct; 32(10):e13388. PubMed ID: 30136315
[TBL] [Abstract][Full Text] [Related]
23. The Epidemiology of UK Autoimmune Liver Disease Varies With Geographic Latitude.
Webb GJ; Ryan RP; Marshall TP; Hirschfield GM
Clin Gastroenterol Hepatol; 2021 Dec; 19(12):2587-2596. PubMed ID: 33493696
[TBL] [Abstract][Full Text] [Related]
24. Transitions between variant forms of primary biliary cirrhosis during long-term follow-up.
Lindgren S; Glaumann H; Almer S; Bergquist A; Björnsson E; Broomé U; Danielsson A; Lebrun B; Prytz H; Olsson R
Eur J Intern Med; 2009 Jul; 20(4):398-402. PubMed ID: 19524182
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic utility of IgG and IgM immunohistochemistry in autoimmune liver disease.
Moreira RK; Revetta F; Koehler E; Washington MK
World J Gastroenterol; 2010 Jan; 16(4):453-7. PubMed ID: 20101770
[TBL] [Abstract][Full Text] [Related]
26. SARS-CoV-2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease.
Duengelhoef P; Hartl J; Rüther D; Steinmann S; Brehm TT; Weltzsch JP; Glaser F; Schaub GM; Sterneck M; Sebode M; Weiler-Normann C; Addo MM; Lütgehetmann M; Haag F; Schramm C; Schulze Zur Wiesch J; Lohse AW
United European Gastroenterol J; 2022 Apr; 10(3):319-329. PubMed ID: 35289983
[TBL] [Abstract][Full Text] [Related]
27. Overlap syndromes.
Beuers U; Rust C
Semin Liver Dis; 2005 Aug; 25(3):311-20. PubMed ID: 16143946
[TBL] [Abstract][Full Text] [Related]
28. Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival.
Al-Chalabi T; Portmann BC; Bernal W; McFarlane IG; Heneghan MA
Aliment Pharmacol Ther; 2008 Jul; 28(2):209-20. PubMed ID: 18433467
[TBL] [Abstract][Full Text] [Related]
29. Autoimmune Hepatitis and PSC Connection.
Vergani D; Mieli-Vergani G
Clin Liver Dis; 2008 Feb; 12(1):187-202, x. PubMed ID: 18242504
[TBL] [Abstract][Full Text] [Related]
30. Twenty-Year Comparative Analysis of Patients With Autoimmune Liver Diseases on Transplant Waitlists.
Webb GJ; Rana A; Hodson J; Akhtar MZ; Ferguson JW; Neuberger JM; Vierling JM; Hirschfield GM
Clin Gastroenterol Hepatol; 2018 Feb; 16(2):278-287.e7. PubMed ID: 28993258
[TBL] [Abstract][Full Text] [Related]
31. Biliary features in liver histology of children with autoimmune liver disease.
Di Giorgio A; D'Adda A; Marseglia A; Sonzogni A; Licini L; Nicastro E; D'Antiga L
Hepatol Int; 2019 Jul; 13(4):510-518. PubMed ID: 31069759
[TBL] [Abstract][Full Text] [Related]
32. Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases.
Muratori P; Muratori L; Guidi M; Maccariello S; Pappas G; Ferrari R; Gionchetti P; Campieri M; Bianchi FB
Clin Exp Immunol; 2003 Jun; 132(3):473-6. PubMed ID: 12780695
[TBL] [Abstract][Full Text] [Related]
33. Autoimmune overlapping syndromes.
Poupon R
Clin Liver Dis; 2003 Nov; 7(4):865-78. PubMed ID: 14594134
[TBL] [Abstract][Full Text] [Related]
34. Sex-related factors in autoimmune liver diseases.
Schwinge D; Schramm C
Semin Immunopathol; 2019 Mar; 41(2):165-175. PubMed ID: 30276446
[TBL] [Abstract][Full Text] [Related]
35. The clinical usage and definition of autoantibodies in immune-mediated liver disease: A comprehensive overview.
Terziroli Beretta-Piccoli B; Mieli-Vergani G; Vergani D
J Autoimmun; 2018 Dec; 95():144-158. PubMed ID: 30366656
[TBL] [Abstract][Full Text] [Related]
36. [Autoimmune liver disease: diagnosis and therapy].
Bayer EM; Schramm C; Kanzler S; Lohse AW
Z Gastroenterol; 2004 Jan; 42(1):19-30. PubMed ID: 14997400
[TBL] [Abstract][Full Text] [Related]
37. Increased Posttransplant Mortality for Autoimmune Hepatitis Compared With Other Autoimmune Liver Diseases.
Lee JY; Danford CJ; Patwardhan VR; Bonder A
J Clin Gastroenterol; 2020 Aug; 54(7):648-654. PubMed ID: 31651572
[TBL] [Abstract][Full Text] [Related]
38. Recurrence of primary sclerosing cholangitis, primary biliary cholangitis and auto-immune hepatitis after liver transplantation.
Visseren T; Darwish Murad S
Best Pract Res Clin Gastroenterol; 2017 Apr; 31(2):187-198. PubMed ID: 28624107
[TBL] [Abstract][Full Text] [Related]
39. Mucosal immunity in liver autoimmunity: a comprehensive review.
Trivedi PJ; Adams DH
J Autoimmun; 2013 Oct; 46():97-111. PubMed ID: 23891169
[TBL] [Abstract][Full Text] [Related]
40. Demonstration of autoantibodies to recombinant human sulphite oxidase in patients with chronic liver disorders and analysis of their clinical relevance.
Preuss B; Berg C; Altenberend F; Gregor M; Stevanovic S; Klein R
Clin Exp Immunol; 2007 Nov; 150(2):312-21. PubMed ID: 17711488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
